PRIMARY OBJECTIVE: To assess the criterion and construct validity and inter-rater reliability of the Czech version of the Mississippi Aphasia Screening Test (MASTcz). RESEARCH DESIGN: Prospective evaluation of consecutive inpatients admitted to the stroke unit of a university hospital within 60 days of onset of a unilateral left hemispheric ischaemic or haemorrhagic stroke with documented aphasia (LHA + ; n = 149). As control groups, unilateral right hemisphere stroke patients without aphasia (RHA-; n = 45) and healthy volunteers recruited from the community to comprise a non-patient control group (CG; n = 243) were examined. METHODS: Data collection included administration of MASTcz (in 52 LHA + patients, repeated by two blinded observers within 24 hours), Edinburgh inventory, Minimental State Examination score and chart review. The presence of aphasia was documented with a standard clinical logopaedic examination and also with the Western Aphasia Battery (WAB) in 45 LHA+ patients. RESULTS: MASTcz displayed high criterion validity (with sensitivity and specificity above 90%) in discrimination between stroke aphasia patients and both control subjects and RHA- stroke patients, high construct validity (close correlation with WAB score; r = 0.933), and acceptable interrater reliability. CONCLUSION: Analyses suggest the usefulness of MASTcz as a reliable and valid screening tool for the detection of aphasia and tracking of its progress.

Department of Neurology Faculty Hospital and Masaryk University Brno Czech Republic

References provided by Crossref.org

Addenbrooke's Cognitive Examination and Individual Domain Cut-Off Scores for Discriminating between Different Cognitive Subtypes of Parkinson's Disease